Wang Luchen, Liu Yanxiang, Gao Haoyu, Xie Mingxin, Zhang Bowen, Zhou Sangyu, Qian Xiangyang, Yu Cuntao, Sun Xiaogang
Department of Vascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, People's Republic of China.
Int J Surg. 2025 Jan 1;111(1):728-736. doi: 10.1097/JS9.0000000000001858.
Normothermic iliac perfusion has been increasingly utilized for thoracoabdominal aortic aneurysm repair; however, the long-term outcomes in large samples are lacking. This study was designed to assess the perioperative and long-term results of thoracoabdominal aortic repair using normothermic iliac perfusion.
The authors retrospectively analyzed 156 patients having Crawford extent II or III thoracoabdominal aortic aneurysm replacement with normothermic iliac perfusion from 2012 to 2022. Primary endpoints were composite adverse events and long-term survival, which encompassed 30-day mortality, persistent stroke, persistent paraplegia, and acute renal failure needing continuous dialysis. The cohort was divided into two subgroups based on the use of selective visceral and cold renal perfusion techniques.
The combined adverse event rate was 14.1%. Specific rates were: 30-day mortality (4.5%), persistent stroke (1.9%), persistent paraplegia (4.5%), and renal failure requiring persistent dialysis (3.2%). The median follow-up time was 67 months. Overall survival rates at 1, 3, 5, 7, and 10 years were 91.6, 90.0, 85.4, 77.6, and 69.7%, respectively. Subgroup analysis showed the visceral and renal perfusion group had a significantly reduced adverse event incidence compared to the nonperfusion group (6.5 vs. 19.1%, P =0.026). Multivariable logistic regression analysis confirmed selective visceral and cold renal perfusion techniques as protective factors against postoperative adverse events (OR 0.30, 95% CI: 0.09-0.94; P =0.038). Multivariable Cox regression analysis identified age ≥50 years (HR 2.63, 95% CI: 1.10-6.27; P =0.029) and NYHA grade ≥III (HR: 3.20, 95% CI: 1.04-9.87; P =0.043) as independent risk factors predicting overall survival.
Normothermic iliac perfusion is a feasible option for thoracoabdominal aortic repair with cost benefits and simpler management, and selective visceral and cold renal perfusion techniques may further improve its safety and effectiveness. However, enhanced vigilance and meticulous care are essential, particularly for elderly patients and those with cardiac insufficiency.
常温髂动脉灌注已越来越多地用于胸腹主动脉瘤修复;然而,缺乏大样本的长期结果。本研究旨在评估使用常温髂动脉灌注进行胸腹主动脉修复的围手术期和长期结果。
作者回顾性分析了2012年至2022年期间156例行CrawfordⅡ或Ⅲ型胸腹主动脉瘤置换并采用常温髂动脉灌注的患者。主要终点是复合不良事件和长期生存,包括30天死亡率、持续性卒中、持续性截瘫以及需要持续透析的急性肾衰竭。根据是否使用选择性内脏和冷肾灌注技术将队列分为两个亚组。
联合不良事件发生率为14.1%。具体发生率分别为:30天死亡率(4.5%)、持续性卒中(1.9%)、持续性截瘫(4.5%)以及需要持续透析的肾衰竭(3.2%)。中位随访时间为67个月。1年、3年、5年、7年和10年的总生存率分别为91.6%、90.0%、85.4%、77.6%和69.7%。亚组分析显示,与非灌注组相比,内脏和肾灌注组的不良事件发生率显著降低(6.5%对19.1%,P = 0.026)。多变量逻辑回归分析证实选择性内脏和冷肾灌注技术是预防术后不良事件的保护因素(OR 0.30,95%CI:0.09 - 0.94;P = 0.038)。多变量Cox回归分析确定年龄≥50岁(HR 2.63,95%CI:1.10 - 6.27;P = 0.029)和纽约心脏协会(NYHA)分级≥Ⅲ级(HR:3.20,95%CI:1.04 - 9.87;P = 0.043)是预测总生存的独立危险因素。
常温髂动脉灌注是胸腹主动脉修复的一种可行选择,具有成本效益且管理更简单,选择性内脏和冷肾灌注技术可能会进一步提高其安全性和有效性。然而,提高警惕和精心护理至关重要,特别是对于老年患者和心功能不全患者。